FDA Planning Study of Generic Metoprolol Over Safety, Efficacy Concerns (FREE)

Extract The FDA is planning an in-depth study of generic extended-release metoprolol succinate after receiving nearly 3500 complaints related to the blood pressure drug...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Primary Care | Study | Toprol